Today's Stock Analyst Downgrades

Explore the most recent stock downgrades, analyst downgrades, and changes to stock analyst ratings in this continuously updated list of analyst recommendations. This page captures each newly issued downgrade, including adjustments to stock ratings, price targets, and analyst coverage, making it easy to follow all the latest downgrades and rating changes.

Company	Action	Brokerage	Analyst	Current Price	Price Target	Rating
AZN AstraZeneca	Downgraded by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		£128.34 -3.9%		Buy
BYRN Byrna Technologies	Downgraded by	Roth Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matt Koranda Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$3.87 -1.8%	$4.50	Buy ➝ Neutral
$Calfrac Well Services Ltd. stock logo$ CFW Calfrac Well Services	Downgraded by	ATB Cormark Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$6.19 +3.9%	C$7.50	Moderate Buy ➝ Hold
CNO CNO Financial Group	Downgraded by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Suneet Kamath Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$51.86 -2.0%	$53.00 ➝ $55.00	Buy ➝ Hold
CZWI Citizens Community Bancorp	Downgraded by	Hovde Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brendan Nosal Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$23.05 +0.1%	$21.00 ➝ $24.00	Outperform ➝ Market Perform
ENIC Enel Chile	Downgraded by	Itau BBA Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$4.46 -0.1%		Market Perform
LAMR Lamar Advertising	Downgraded by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jason Bazinet Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$155.18 -4.4%	$145.00 ➝ $160.00	Buy ➝ Neutral
ONT Oxford Nanopore Technologies	Downgraded by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 120.30 +1.2%		Buy
PEP PepsiCo	Downgraded by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Filippo Falorni Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$137.38 -0.3%	$170.00 ➝ $145.00	Buy ➝ Neutral
QBR.B Quebecor	Downgraded by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$66.68 -3.1%	C$68.00	Buy ➝ Hold
A letter from Shannon Stansberry (Ad) Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down year in nearly two decades and total gains of almost 2,000% - his immediate reaction was disbelief. It took a trusted friend's personal vouching for Emmet Savage and a face-to-face trip to Ireland to change his mind. The full documentary, Investigating Project Prophet, is now live. Watch the full story and see the verified track record for yourself
SHOP Shopify	Downgraded by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tyler Radke Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$122.54 -0.5%		Market Outperform ➝ Neutral
SN Smith & Nephew	Downgraded by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 1,140 +0.8%		Buy
TRV Travelers Companies	Downgraded by	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$338.80 +0.4%	$329.00	Outperform ➝ Hold
WEIR The Weir Group	Downgraded by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 2,370 +0.3%		Buy

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 07:17 AM ET.

Frequently Asked Questions

Analyst ratings are the "buy" and "sell" labels, plus price targets, that investment researchers attach to specific securities. These ratings are based on financial data, earnings reports and conversations with company executives.

Analyst ratings provide plenty of helpful information, but you shouldn't use an analyst's "buy" rating as the sole reason you purchase a security. Analysts aren't immune to conflicts of interest or outside parties' influence, so ensure you always understand why a stock was labeled a "buy" or "sell."

Ratings give investors the analyst's overall opinion about a particular stock and price targets based on the company's valuation and prospects. Analysts often attend conference calls, ask questions and provide in-depth information about companies that are difficult to acquire elsewhere.

Stock Analyst Downgrades

Frequently Asked Questions

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Top Stock Recommendations by Brokerage

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Stock Analyst Downgrades

Frequently Asked Questions

What are analyst ratings?

Should you trust analyst ratings?

What does an analyst rating tell you about a stock?

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Top Stock Recommendations by Brokerage

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools